Kevin Durning

US Chief Financial Officer and Vice President, Finance (Interim)


Kevin oversees all Finance, Procurement and Facilities matters in the United States of America and is a member of the North American Governance Committee, the US Leadership Team and Chair of the AstraZeneca Investment Committee.

Prior Experience

Prior to assuming his current role in 2022, he held the role of Head of Business Planning and Analysis since 2021. Kevin joined AstraZeneca more than 23 years ago and has held various senior finance roles, including US Controller, Executive Director of Pricing, Contracting & Government Reporting, Head of Finance for Specialty Care and Head of Financial Planning & Reporting.


  •        Master of Business Administration, Villanova University, Villanova, PA
  •        Bachelor of Science, Villanova University, Villanova, PA


  •       Member of the Institute of Management Accountants (IMA)
  •       Certified Management Accountant (CMA)